JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 45 filers reported holding JANUX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $283 | -99.9% | 21,469 | -35.6% | 0.04% | -37.7% |
Q3 2022 | $452,000 | +9.7% | 33,352 | -1.2% | 0.07% | -5.5% |
Q2 2022 | $412,000 | +1.7% | 33,750 | +19.4% | 0.07% | +10.6% |
Q1 2022 | $405,000 | -36.1% | 28,258 | -12.0% | 0.07% | -38.9% |
Q4 2021 | $634,000 | +41.2% | 32,128 | +54.6% | 0.11% | +100.0% |
Q3 2021 | $449,000 | – | 20,777 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
FMR LLC | 10,281,288 | $124,403,584 | 0.01% |